Insider Trading activities of Progenics Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Progenics Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Progenics Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Progenics Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PGNX. The reporting company's CIK number is 835887.
The total value of stock buying since 2005 is $8,030,657.
The total value of stock sales since 2005 is $30,175,090.
The total value of stock option exercises since 2005 is $9,042,404.


Go to page:  1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Progenics Pharmaceuticals Inc (PGNX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 0 $0 953,900 $9,227,413 0 $0
2015-06 0 $0 2,000 $13,660 2,000 $10,660
2015-03 0 $0 10,000 $67,110 10,000 $50,209
2015-01 0 $0 2,000 $14,112 2,000 $10,660
2014-12 0 $0 3,000 $21,201 3,000 $16,049
2014-11 0 $0 24,000 $163,950 24,000 $126,600
2014-07 1,625,436 $7,476,167 0 $0 0 $0
2013-07 0 $0 5,000 $31,650 5,000 $26,650
2013-03 650 $3,469 0 $0 2,500 $9,097
2013-01 1,215 $3,432 0 $0 0 $0
2012-12 1,142 $3,437 0 $0 0 $0
2012-11 112,033 $199,577 0 $0 0 $0
2012-10 1,162 $3,433 0 $0 0 $0
2012-09 1,036 $3,439 0 $0 0 $0
2012-08 815 $3,450 0 $0 0 $0
2012-07 346 $3,472 1,000 $9,790 1,000 $5,330
2012-06 375 $3,474 1,000 $8,508 1,000 $5,330
2012-05 445 $3,475 1,000 $10,927 1,000 $5,330
2012-04 348 $3,514 1,000 $9,852 1,000 $5,330
2012-03 343 $3,472 1,000 $9,817 1,000 $5,330
2012-02 369 $3,484 35,250 $359,205 2,250 $13,955
2012-01 755 $6,924 1,000 $8,780 1,000 $5,330
2011-12 0 $0 1,000 $6,660 1,000 $5,330
2011-11 0 $0 1,634 $9,785 1,000 $5,330
2011-10 532 $3,467 1,000 $6,330 15,104 $70,545
2011-09 542 $3,460 1,000 $6,329 1,000 $5,329
2011-08 571 $3,471 1,000 $6,330 1,000 $5,330
2011-07 567 $3,471 1,000 $7,205 42,968 $233,998
2011-06 490 $3,469 14,761 $106,382 1,000 $5,330
2011-05 486 $3,465 21,000 $172,290 1,000 $5,330
2011-04 479 $3,467 1,000 $6,330 13,222 $67,376
2011-03 0 $0 1,000 $6,330 33,500 $48,555
2011-02 0 $0 7,597 $48,089 7,597 $40,492
2011-01 0 $0 403 $2,550 13,702 $66,353
2010-12 5,000 $24,500 0 $0 0 $0
2010-11 5,000 $23,800 0 $0 0 $0
2010-10 5,000 $24,950 0 $0 41,475 $179,086
2010-09 5,000 $20,500 0 $0 0 $0
2010-08 5,000 $23,750 0 $0 0 $0
2010-07 5,000 $24,925 0 $0 16,056 $71,288
2010-06 5,000 $24,950 17,281 $101,687 0 $0
2010-05 5,000 $24,550 0 $0 0 $0
2010-04 0 $0 0 $0 20,792 $94,726
2010-03 0 $0 9,221 $49,429 0 $0
2010-01 0 $0 0 $0 18,226 $68,947
2009-10 18,500 $90,243 0 $0 15,442 $65,765
2009-07 0 $0 0 $0 43,354 $231,075
2009-06 0 $0 9,500 $47,548 0 $0
2009-04 0 $0 0 $0 12,279 $69,376
2009-01 0 $0 0 $0 7,849 $71,660
2008-10 0 $0 62,500 $577,625 37,563 $245,280
2008-09 0 $0 1,000 $15,000 1,000 $12,290
2008-08 0 $0 1,000 $16,465 51,000 $493,540
2008-07 0 $0 11,000 $175,942 27,040 $298,518
2008-06 0 $0 1,000 $16,397 1,000 $12,290
2008-05 0 $0 1,000 $15,000 8,500 $52,512
2008-04 0 $0 1,000 $15,000 14,792 $102,212
2008-03 0 $0 1,000 $15,300 8,500 $47,247
2008-02 0 $0 1,000 $16,440 1,000 $12,290
2008-01 0 $0 1,000 $18,120 5,986 $88,793
2007-12 0 $0 6,000 $115,351 6,000 $42,040
2007-10 0 $0 27,000 $616,692 49,797 $646,256
2007-09 0 $0 24,000 $565,908 24,000 $127,920
2007-08 0 $0 26,000 $578,410 26,000 $158,734
2007-07 0 $0 26,000 $560,601 36,536 $422,852
2007-06 0 $0 14,000 $305,066 14,000 $94,774
2007-05 0 $0 26,000 $613,960 26,000 $158,734
2007-04 0 $0 30,000 $769,362 34,393 $384,612
2007-03 0 $0 36,000 $898,714 36,000 $198,734
2007-02 0 $0 62,000 $1,858,002 62,000 $332,680
2007-01 0 $0 38,500 $1,062,826 51,232 $478,080
2006-12 0 $0 50,000 $1,344,807 50,000 $258,300
2006-11 0 $0 52,000 $1,433,356 52,000 $262,734
2006-10 0 $0 33,000 $789,341 38,192 $371,915
2006-09 0 $0 29,000 $672,728 29,000 $147,920
2006-08 0 $0 29,000 $609,252 29,000 $147,920
2006-07 0 $0 29,000 $658,453 43,904 $532,616
2006-06 0 $0 37,025 $803,159 15,000 $73,300
2006-05 0 $0 39,000 $897,840 39,000 $182,600
2006-04 0 $0 25,000 $639,440 29,231 $271,170
2006-03 0 $0 32,000 $905,380 32,000 $154,600
2006-02 0 $0 50,500 $1,407,893 49,000 $318,850
2006-01 0 $0 8,000 $221,064 12,528 $203,010
2005-09 0 $0 5,000 $125,000 0 $0
2005-06 0 $0 15,150 $301,947 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Progenics Pharmaceuticals Inc insiders (PGNX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-15 Kotler Kevin Sale 150,000 9.55 1,432,500
2017-02-14 Kotler Kevin Sale 352,600 9.70 3,418,457
2017-02-13 Kotler Kevin Sale 100,000 9.70 969,999
2017-02-09 Broadfin Capital, Llc Sale 201,300 9.70 1,952,207
2017-02-07 Broadfin Capital, Llc Sale 150,000 9.70 1,454,250
2015-06-11 Israel Robert J (Executive Vice President, Medi) Sale 2,000 6.83 13,660
2015-06-11 Israel Robert J (Executive Vice President, Medi) Option Ex 2,000 5.33 10,660
2015-03-13 Israel Robert J (Executive Vice President, Medi) Sale 3,000 7.00 21,000
2015-03-13 Israel Robert J (Executive Vice President, Medi) Option Ex 3,000 5.35 16,049
2015-03-11 Israel Robert J (Executive Vice President, Medi) Sale 2,000 6.83 13,660
2015-03-11 Israel Robert J (Executive Vice President, Medi) Option Ex 2,000 5.33 10,660
2015-03-03 Israel Robert J (Executive Vice President, Medi) Sale 5,000 6.49 32,450
2015-03-03 Israel Robert J (Executive Vice President, Medi) Option Ex 5,000 4.70 23,500
2015-01-12 Israel Robert J (Executive Vice President, Medi) Sale 2,000 7.06 14,112
2015-01-12 Israel Robert J (Executive Vice President, Medi) Option Ex 2,000 5.33 10,660
2014-12-11 Israel Robert J (Executive Vice President, Medi) Sale 3,000 7.07 21,201
2014-12-11 Israel Robert J (Executive Vice President, Medi) Option Ex 3,000 5.35 16,049
2014-11-21 Israel Robert J (Executive Vice President, Medi) Sale 9,000 7.00 63,000
2014-11-21 Israel Robert J (Executive Vice President, Medi) Option Ex 9,000 5.35 48,150
2014-11-13 Israel Robert J (Executive Vice President, Medi) Sale 10,000 6.83 68,300
2014-11-13 Israel Robert J (Executive Vice President, Medi) Option Ex 10,000 5.33 53,300
2014-11-11 Israel Robert J (Executive Vice President, Medi) Sale 5,000 6.53 32,650
2014-11-11 Israel Robert J (Executive Vice President, Medi) Option Ex 5,000 5.03 25,150
2014-07-21 Kotler Kevin Buy 388,659 4.73 1,838,357
2014-07-18 Kotler Kevin Buy 388,200 4.73 1,836,186
2014-07-17 Kotler Kevin Buy 436,884 4.48 1,957,240
2014-07-16 Kotler Kevin Buy 411,693 4.48 1,844,384
2013-07-18 Israel Robert J (Senior VP Medical Affairs) Sale 5,000 6.33 31,650
2013-07-18 Israel Robert J (Senior VP Medical Affairs) Option Ex 5,000 5.33 26,650
2013-03-27 Baker Mark Robert (CEO) Buy 650 5.34 3,469
2013-03-22 Scheinberg David A (Director) Option Ex 2,500 3.64 9,097
2013-01-22 Baker Mark Robert (CEO) Buy 1,215 2.83 3,432
2012-12-26 Baker Mark Robert (CEO) Buy 1,142 3.01 3,437
2012-11-28 Baker Mark Robert (CEO) Buy 1,607 2.13 3,419
2012-11-19 Baker Mark Robert (CEO) Buy 11,800 1.96 23,104
2012-11-16 Baker Mark Robert (CEO) Buy 49,793 1.82 90,722
2012-11-15 Baker Mark Robert (CEO) Buy 48,833 1.69 82,332
2012-10-24 Baker Mark Robert (CEO) Buy 1,162 2.96 3,433
2012-09-26 Baker Mark Robert (CEO) Buy 1,036 3.32 3,439
2012-08-22 Baker Mark Robert (CEO) Buy 815 4.23 3,450
2012-07-25 Baker Mark Robert (CEO) Buy 346 10.04 3,472
2012-07-02 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 9.79 9,790
2012-07-02 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-06-27 Baker Mark Robert (CEO) Buy 375 9.27 3,474
2012-06-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 8.51 8,508
2012-06-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-05-23 Baker Mark Robert (CEO) Buy 445 7.81 3,475
2012-05-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 10.93 10,927
2012-05-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-04-25 Baker Mark Robert (CEO) Buy 348 10.10 3,514
2012-04-02 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 9.85 9,852
2012-04-02 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-03-28 Baker Mark Robert (CEO) Buy 343 10.12 3,472
2012-03-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 9.82 9,817
2012-03-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-02-23 Scheinberg David A (Director) Sale 1,250 10.00 12,500
2012-02-23 Scheinberg David A (Director) Option Ex 1,250 6.90 8,625
2012-02-22 Baker Mark Robert (CEO) Buy 369 9.44 3,484
2012-02-03 Briner Kurt W (Director) Sale 33,000 10.22 337,227
2012-02-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 9.48 9,478
2012-02-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2012-01-25 Baker Mark Robert (CEO) Buy 364 9.50 3,458
2012-01-11 Baker Mark Robert (CEO) Buy 391 8.87 3,466
2012-01-03 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 8.78 8,780
2012-01-03 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-12-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 6.66 6,660
2011-12-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-11-23 Baker Mark Robert (CEO) Sale 634 5.45 3,455
2011-11-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 6.33 6,330
2011-11-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-10-26 Baker Mark Robert (CEO) Buy 532 6.52 3,467
2011-10-05 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 6.33 6,330
2011-10-05 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-10-03 Baker Mark Robert (CEO) Option Ex 5,124 4.62 23,693
2011-10-03 Olson William C (Senior VP, Research and Develo) Option Ex 2,605 4.62 12,045
2011-10-03 Mckinney Robert A (Senior VP, CFO) Option Ex 2,737 4.62 12,655
2011-10-03 Israel Robert J (Senior VP Medical Affairs) Option Ex 3,638 4.62 16,822
2011-09-28 Baker Mark Robert (CEO) Buy 542 6.38 3,460
2011-09-27 Israel Robert J (Senior VP Medical Affairs) Sale 746 6.33 4,722
2011-09-27 Israel Robert J (Senior VP Medical Affairs) Option Ex 746 5.33 3,976
2011-09-20 Israel Robert J (Senior VP Medical Affairs) Sale 100 6.33 633
2011-09-20 Israel Robert J (Senior VP Medical Affairs) Option Ex 100 5.33 533
2011-09-01 Israel Robert J (Senior VP Medical Affairs) Sale 154 6.33 974
2011-09-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 154 5.33 820
2011-08-24 Baker Mark Robert (CEO) Buy 571 6.08 3,471
2011-08-11 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 6.33 6,330
2011-08-11 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-07-27 Baker Mark Robert (CEO) Buy 567 6.12 3,471
2011-07-01 Baker Mark Robert (CEO) Option Ex 20,032 5.46 109,374
2011-07-01 Olson William C (Senior VP, Research and Develo) Option Ex 6,335 5.46 34,589
2011-07-01 Mckinney Robert A (Senior VP, CFO) Option Ex 7,279 5.46 39,743
2011-07-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 7.21 7,205
2011-07-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 9,322 5.39 50,292
2011-06-22 Baker Mark Robert (CEO) Buy 490 7.08 3,469
2011-06-21 Olson William C (Senior VP, Research and Develo) Sale 2,872 7.10 20,388
2011-06-21 Israel Robert J (Senior VP Medical Affairs) Sale 7,889 7.01 55,341
2011-06-17 Mckinney Robert A (Senior VP, CFO) Sale 3,000 7.50 22,500
2011-06-01 Israel Robert J (Senior VP Medical Affairs) Sale 1,000 8.15 8,153
2011-06-01 Israel Robert J (Senior VP Medical Affairs) Option Ex 1,000 5.33 5,330
2011-05-25 Baker Mark Robert (CEO) Buy 486 7.13 3,465
2011-05-16 Briner Kurt W (Director) Sale 5,000 8.19 40,925
2011-05-13 Briner Kurt W (Director) Sale 15,000 8.27 123,975
2011-05-02 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 7.39 7,390
2011-05-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,000 5.33 5,330
2011-04-27 Baker Mark Robert (CEO) Buy 479 7.24 3,467
2011-04-01 Baker Mark Robert (President) Option Ex 4,022 5.05 20,311
2011-04-01 Olson William C (SR. VP, Research & Development) Option Ex 2,373 5.05 11,983
2011-04-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,495 5.05 12,599
2011-04-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,000 6.33 6,330
2011-04-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 4,332 5.19 22,483
2011-03-29 Israel Robert J (Sr. VP, Medical Affairs) Sale 800 6.33 5,064
2011-03-29 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 800 5.33 4,264
2011-03-09 Goff Stephen P (Director) Option Ex 32,500 1.33 43,225
2011-03-08 Israel Robert J (Sr. VP, Medical Affairs) Sale 200 6.33 1,266
2011-03-08 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 200 5.33 1,066
2011-02-07 Israel Robert J (Sr. VP, Medical Affairs) Sale 7,597 6.33 48,089
2011-02-07 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 7,597 5.33 40,492
2011-01-19 Israel Robert J (Sr. VP, Medical Affairs) Sale 403 6.33 2,550
2011-01-19 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 403 5.33 2,147
2011-01-03 Baker Mark Robert (President) Option Ex 4,377 4.83 21,132
2011-01-03 Olson William C (SR. VP, Research & Development) Option Ex 2,582 4.83 12,465
2011-01-03 Mckinney Robert A (Chief Financial Officer) Option Ex 2,715 4.83 13,108
2011-01-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 3,625 4.83 17,501
2010-12-01 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.90 24,500
2010-11-01 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.76 23,800
2010-10-04 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.99 24,950
2010-10-01 Baker Mark Robert (President) Option Ex 17,545 4.32 75,759
2010-10-01 Olson William C (SR. VP, Research & Development) Option Ex 6,915 4.32 29,858
2010-10-01 Mckinney Robert A (Chief Financial Officer) Option Ex 8,229 4.32 35,532
2010-10-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 8,786 4.32 37,937
2010-09-01 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.10 20,500
2010-08-02 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.75 23,750
2010-07-16 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.99 24,925
2010-07-01 Baker Mark Robert (President) Option Ex 4,575 4.44 20,313
2010-07-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,675 4.44 11,877
2010-07-01 Olson William C (SR. VP, Research & Development) Option Ex 2,541 4.44 11,282
2010-07-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,675 4.44 11,877
2010-07-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 3,590 4.44 15,939
2010-06-22 Baker Mark Robert (President) Sale 2,328 5.66 13,185
2010-06-22 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,409 5.74 13,818
2010-06-22 Olson William C (VP, Research & Development) Sale 2,364 5.80 13,723
2010-06-22 Israel Robert J (Sr. VP, Medical Affairs) Sale 6,180 5.82 35,961
2010-06-18 Mckinney Robert A (Chief Financial Officer) Sale 4,000 6.25 25,000
2010-06-01 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.99 24,950
2010-05-20 Maddon Paul J (Chief Executive Officer/CSO) Buy 5,000 4.91 24,550
2010-04-01 Baker Mark Robert (President) Option Ex 4,300 4.56 19,590
2010-04-01 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 5,242 4.56 23,882
2010-04-01 Olson William C (VP, Research & Development) Option Ex 2,490 4.56 11,344
2010-04-01 Mckinney Robert A (Chief Financial Officer) Option Ex 2,621 4.56 11,941
2010-04-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 3,518 4.56 16,028
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of PGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Progenics Pharmaceuticals Inc (symbol PGNX, CIK number 835887) see the Securities and Exchange Commission (SEC) website.